Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,442.21
    +60.86 (+0.73%)
     
  • Bitcoin USD

    62,954.18
    +1,837.94 (+3.01%)
     
  • CMC Crypto 200

    1,302.13
    -55.88 (-4.11%)
     
  • S&P 500

    5,237.19
    +23.11 (+0.44%)
     
  • Dow

    39,555.73
    +167.97 (+0.43%)
     
  • Nasdaq

    16,421.88
    +75.61 (+0.46%)
     
  • Gold

    2,373.90
    +33.60 (+1.44%)
     
  • Crude Oil

    79.81
    +0.55 (+0.69%)
     
  • 10-Yr Bond

    4.4870
    +0.0380 (+0.85%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Could Novavax's Next Step Make It a Multibagger?

Could Novavax's Next Step Make It a Multibagger?

Novavax disappointed investors when its regulatory submissions fell behind. Now, all eyes are on Novavax's next step: winning authorization in the U.S. Could this nudge the stock out of its slump -- and even turn it into a multibagger? Novavax reported revenue of $704 million and net income of $203 million.